Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $205,100 - $263,118
-1,315 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $238,527 - $307,749
1,315 New
1,315 $248,000
Q1 2020

Apr 17, 2020

SELL
$92.66 - $144.94 $491,098 - $768,182
-5,300 Closed
0 $0
Q4 2019

Jan 30, 2020

SELL
$116.25 - $133.25 $326,895 - $374,699
-2,812 Reduced 34.66%
5,300 $701,000
Q3 2019

Oct 25, 2019

BUY
$112.57 - $128.43 $913,167 - $1.04 Million
8,112 New
8,112 $1.01 Million
Q2 2019

Aug 05, 2019

SELL
$97.98 - $114.28 $1.37 Million - $1.6 Million
-13,957 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $1.14 Million - $1.41 Million
13,957 New
13,957 $1.41 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Arabesque Asset Management LTD Portfolio

Follow Arabesque Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Arabesque Asset Management LTD with notifications on news.